ADDvise Group’s Dubai-based subsidiary MRC Systems has received a further order from BioGeneric Pharma, a biotech factory based in Cairo, Egypt.
The order is worth approximately $1.7m and is an add-on-project in the ongoing project between the parties regarding design, supply, and commissioning of cleanroom environment to be used for production of mRNA-vaccine.
BioGeneric Pharma has been selected by the World Health Organization (WHO) to be the first technology transfer recipient of mRNA-vaccine hub in Egypt for distribution in Africa.
Delivery of the order is planned to take place during Q2 2023. "We are happy to contribute with our knowledge and expertise in the cleanroom space," ADDvise stated.